Amylyx Pharmaceuticals, Inc.
看多
已更新

$AMLX, following the Bio Techs

103
The health care industry is being leading the charge, AMLX is the proof of that. This recent IPO just broke out of a good looking cup & handle pattern. Also, IBD is giving a 99 relative strength rating.

So, I enter today with a small position. A "pilot position", as Mark Minervini would say. The market is still under pressure so I'm testing it.

As this stock is a highly volatile I'll play for a 3:1 risk/reward.

註釋
Just put my stop loss at breakeven
註釋
I sold my position at breakeven just be sure. The thing is that the price hasn't break support at its MAs.

I'll keep a close eye on this one for thise week's action.

免責聲明

這些資訊和出版物並非旨在提供,也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。